Adaptive Biotechnologies (ADPT) Director Sells $1.05M in Stock

AI Summary

Michelle Griffin, a director at Adaptive Biotechnologies (ADPT), sold shares worth $1.05 million. This transaction raises potential concerns regarding insider selling activity and its implications for investor confidence. The market often reacts to such insider trades, which can influence stock performance. Investors may interpret this sale as a signal regarding the company's future prospects.